Pfizer and Moderna stocks bucked the trend and soared after the news of a potential "deadlier version of Covid." ...

The virus does not enter human cells as readily as SARS-CoV-2 does, the Chinese researchers reported in the journal Cell, ...

An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...

Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Researchers from the Wuhan Institute of Virology in China have discovered a new strain of the coronavirus in bats, which ...

The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...

PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.